Dr. Pamela Frank, BSc (Hons), ND

 

Subheadline

A clinical review of the bidirectional relationship between reproductive hormones and inflammation, with evidence-based nutrition, lifestyle, and botanical interventions.

 

Short Description

This article explores the complex interplay between reproductive hormones and systemic inflammation and its role in conditions such as PCOS, endometriosis, and perimenopause. It outlines integrative, evidence-based strategies—including diet, exercise, stress modulation, supplementation, and botanical medicine—to restore balance and improve clinical outcomes.

 

Abstract

Reproductive hormones and inflammatory pathways are deeply interconnected in a bidirectional relationship that affects menstrual health, fertility, pain, metabolic function, and overall well-being. Disturbances in inflammatory balance can impair hormone synthesis and signaling, while hormonal imbalances can amplify inflammatory cascades. This article synthesizes current mechanistic and clinical evidence linking estrogen, progesterone, testosterone, and cortisol with systemic and reproductive inflammation. It further outlines evidence-based dietary, lifestyle, nutraceutical, and botanical interventions that support the hormone-inflammation axis, with clinical considerations for PCOS, endometriosis, and perimenopause. Understanding and targeting this bidirectional network is essential for optimizing outcomes in patients with hormone-related inflammatory conditions.

 

Introduction

Reproductive health disorders such as polycystic ovary syndrome (PCOS), endometriosis, dysmenorrhea, and perimenopausal symptoms are increasingly recognized as systemic inflammatory conditions, not merely endocrine disorders. Chronic low-grade inflammation alters hypothalamic-pituitary-gonadal (HPG) axis function, interferes with ovulation, contributes to pain, and exacerbates metabolic dysfunction. Conversely, reproductive hormones, particularly estrogen and progesterone, influence inflammatory pathways including cytokine signaling, prostaglandin synthesis, immune cell activity, and oxidative stress responses. The resulting cycle can perpetuate symptoms unless addressed comprehensively.

 

The Hormone-Inflammation Axis

• Estrogen – Dual Roles in Inflammation: Estrogen exerts both anti-inflammatory and pro-inflammatory effects depending on context. Physiologic estradiol suppresses IL-6 and TNF-α, modulates immune tolerance, and supports antioxidant pathways. Elevated estrogen, whether due to metabolic dysfunction, obesity, or impaired detoxification, can increase COX-2 activity, mast cell activation, and prostaglandin production, thereby worsening dysmenorrhea, endometriosis, and breast tenderness.
• Progesterone and Immune Regulation: Progesterone is distinctly anti-inflammatory. Through inhibition of NF-κB and suppression of IL-1β and TNF-α, it supports implantation, reduces PMS symptoms, and promotes tissue repair. Luteal phase progesterone deficiency is associated with elevated inflammation, dysmenorrhea, and reduced fertility.
• Testosterone and Metabolic Inflammation: In both sexes, low testosterone correlates with elevated CRP, IL-6, and metabolic dysfunction. In PCOS, hyperandrogenism coexists with inflammation driven by insulin resistance, adipose tissue cytokine production, and oxidative stress.
• Cortisol and HPA-HPG Axis Interactions: Chronic stress alters cortisol secretion patterns, elevates inflammatory cytokines two- to three-fold, suppresses GnRH pulsatility, and disrupts menstrual cycles. Chronic stress and/or HPA-axis dysfunction are therefore both a cause and consequence of reproductive hormone disturbances.

 

Key Inflammatory Pathways

• Cyclooxygenase (COX) Pathways: COX-1 and COX-2 regulate prostaglandin synthesis. Excess COX-2 activity contributes to menstrual pain, endometriosis lesions, and pelvic inflammation.
• NF-κB: The Master Switch: NF-κB links hormonal signals to inflammatory gene expression. Many botanicals and nutrients, including curcumin, magnesium, and omega-3 fatty acids, work partially by inhibiting NF-κB activation.
• Cytokines and Complement: Imbalances in cytokines (IL-6, IL-1β, TNF-α) impair follicular development, ovulation, and implantation. Complement activation also contributes to endometriosis severity.

 

Clinical Manifestations

• Endometriosis: Marked by chronic pelvic inflammation, cytokine excess, oxidative stress, and immune dysfunction. Patients experience dysmenorrhea, dyspareunia, infertility, and fatigue.
• PCOS: PCOS is a metabolic-inflammatory disorder featuring insulin resistance, elevated CRP, androgen excess, follicular arrest, and oligo- or anovulation.
• Perimenopause and Menopause: Declining hormones shift inflammatory tone, raising cardiovascular risk, altering body composition, and contributing to vasomotor symptoms.

 

Assessment and Laboratory Evaluation

Target optimal levels. Assessment includes:

• Reproductive hormones (cycle-timed)  – LH, FSH, and estradiol on cycle day 3, 7 days post-ovulation progesterone 
• Cortisol awakening response  
• Thyroid panel  – TSH, free T3, free T4, anti-TPO, anti-thyroglobulin, reverse T3
• hs-CRP, ESR, cytokine markers – IL-6 levels are readily available. Other cytokines, like NF-kB are only available in research settings. 
• Fasting glucose, insulin, HOMA-IR  
• Lipid profile, omega-3 index  
• Nutrient status: 25-hydroxy vitamin D, B-vitamins, magnesium, zinc, selenium  

Dietary Interventions

• Mediterranean Diet: Systematic reviews confirm significant reductions in CRP and IL-6 and improved reproductive outcomes.
• Low-Glycemic Index and Low-Glycemic Load Eating: Lowers insulin resistance and inflammation, particularly effective for PCOS.
• Omega-3 Fatty Acids: EPA+DHA reduces prostaglandin E2, pelvic pain, and inflammation. Therapeutic doses: 2-4 g/day.

Key Nutritional Strategies

• Fiber: 25-35 g/day to support estrogen metabolism  
• Phytoestrogens (soy, flax): provide selective estrogen receptor modulation  
• Antioxidants (berries, tea, leafy greens): reduce oxidative stress  

Exercise as Anti-Inflammatory Medicine

Moderate aerobic exercise reduces CRP by 30-40%, lowers IL-6 and TNF-α, and improves ovulation and insulin sensitivity. Resistance training supports metabolism, muscle mass, and bone density.

Stress, Sleep, and HPA Axis Interventions

Mind-body therapies (Mindfulness-Based Stress Reduction, yoga, meditation, CBT) reduce cortisol 20-30%, improve inflammatory markers, and support menstrual regularity. Sleep deprivation raises inflammatory cytokines within 48 hours. Healthy melatonin levels contribute to ovarian function, egg quality, reduced oxidative stress and inflammation control.

Nutritional Supplementation

• Vitamin D: Modulates immune function and improves symptoms of PCOS, endometriosis, and inflammation.  Dose: 1000 to 4000 IU depending on the blood level. 
• B-complex: Methylated B’s and pyridoxal-5-phosphate support methylation, estrogen metabolism and adrenal function.  
• Magnesium glycinate or bisglycinate: Reduces menstrual pain up to 50%.  Dose: 250-400 mg per day. 
• Zinc and Selenium: Support thyroid, antioxidant systems, and androgen regulation.  Dose: Zinc 25-30 mg elemental zinc with a substantial meal. Selenium: 100-200 mcg per day with food. 
• NAC: Enhances ovulation and estrogen metabolism, reduces inflammation, supports endometriosis outcomes.  Dose: 600 mg tid with food. 
• CoQ10: Improves metabolic function, particularly in PCOS. Dose: 200 to 600 mg per day. 

 

Botanical Medicine

• Vitex: Regulates prolactin, improves progesterone production, and symptoms of PMS.  Dose: Dosing varies considerably across studies. In one, 225 mg per day of an extract standardized to 0.6 percent of the constituent agnuside was used. Dosage of the fruit extract is 20 to 40 mg per day, although higher doses (up to 1,800 mg per day) also have been used. Fluid extract (40 drops daily) and tincture (35 to 45 drops, three times daily) also have been used.
• Peony [6-12 g/day (raw herb equivalent)] + Licorice [3-6 g/day]: Reduces androgens in PCOS.  Avoid use in hypertensive patients. Monitor BP weekly while using. 
• Curcumin: Inhibits NF-κB and COX-2 and reduces pain.  Dose: 500-1,500 mg/day of curcumin extract (with a bioavailability enhancer like piperine) 
• Boswellia: Inhibits 5-LOX and reduces dysmenorrhea and pelvic pain.  Dose: 900-1,200 mg/day in divided doses, standardized to AKBA (acetyl-11-keto-β-boswellic acid).  
• Ginger: Comparable to NSAIDs for menstrual pain in RCTs.  Dose: 250-500 mg 2-4×/day (typically 1,000-2,000 mg/day total). Dysmenorrhea trials commonly use 1,000-1,500 mg/day.
• Ashwagandha: Reduces cortisol 14-28%. Always measure cortisol to determine whether it needs reducing. Don’t guess or assume. Dose: 300-600 mg/day of a 12:1 root extract, standardized to 5% withanolides. 
• Rhodiola, Ginseng: Improve fatigue and resilience. Dose: Rhodiola – 200-400 mg/day standardized to rosavins/salidrosides. Ginseng – 200-400 mg/day standardized extract.  

Clinical Applications

PCOS Protocol includes Mediterranean/low-GI/GL diet, omega-3s, vitamin D based on measured levels, NAC, magnesium, resistance + aerobic exercise, and cycle-specific botanicals.

Endometriosis Protocol emphasizes anti-inflammatory nutrition, omega-3s, curcumin, NAC, vitamin E, pelvic floor physiotherapy, and ginger.

Perimenopause Protocol includes phytoestrogens, black cohosh, HPA axis support, magnesium, omega-3s, sleep optimization, and bone-supportive exercise.

Conclusion

The hormone-inflammation relationship is multidirectional and clinically significant. Successful treatment requires addressing inflammatory pathways alongside endocrine regulation. Diet, movement, stress reduction, sleep optimization, supplements, and botanical medicine form the evidence-based foundation of effective integrative care.

 

References

1. Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, Gómez-Gracia E, Ruiz-Gutiérrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pintó X, Basora J, Muñoz MA, Sorlí JV, Martínez JA, Fitó M, Gea A, Hernán MA, Martínez-González MA; PREDIMED Study Investigators. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N Engl J Med. 2018 Jun 21;378(25):e34. doi: 10.1056/NEJMoa1800389. Epub 2018 Jun 13. PMID: 29897866. 
2. Zwahlen M, Stute P. Impact of progesterone on the immune system in women: a systematic literature review. Arch Gynecol Obstet. 2024 Jan;309(1):37-46. doi: 10.1007/s00404-023-06996-9. Epub 2023 Mar 18. PMID: 36933040; PMCID: PMC10024519. 
3. Repaci A, Gambineri A, Pasquali R. The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol. 2011 Mar 15;335(1):30-41. doi: 10.1016/j.mce.2010.08.002. Epub 2010 Aug 11. PMID: 20708064. 
4. Straub RH. The complex role of estrogens in inflammation. Endocr Rev. 2007 Aug;28(5):521-74. doi: 10.1210/er.2007-0001. Epub 2007 Jul 19. PMID: 17640948. 
5. Berga, SL, et al, Neuroendocrine Aberrations in Women With Functional Hypothalamic Amenorrhea, The Journal of Clinical Endocrinology & Metabolism, Volume 68, Issue 2, 1 February 1989, Pages 301-308, https://doi.org/10.1210/jcem-68-2-301 
6. Andrew Steptoe, Mark Hamer, Yoichi Chida, The effects of acute psychological stress on circulating inflammatory factors in humans: A review and meta-analysis, Brain, Behavior, and Immunity, Volume 21, Issue 7, 2007, Pages 901-912, ISSN 0889-1591,https://doi.org/10.1016/j.bbi.2007.03.011.
7. Rivier C, Rivest S. Effect of stress on the activity of the hypothalamic-pituitary-gonadal axis: peripheral and central mechanisms. Biol Reprod. 1991 Oct;45(4):523-32. doi: 10.1095/biolreprod45.4.523. PMID: 1661182. 
8. Orsi, N.M. and Tribe, R.M. (2008), Cytokine Networks and the Regulation of Uterine Function in Pregnancy and Parturition. Journal of Neuroendocrinology, 20: 462-469. https://doi.org/10.1111/j.1365-2826.2008.01668.x 
9. Agostinis C, Balduit A, Mangogna A, Zito G, Romano F, Ricci G, Kishore U, Bulla R. Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target. Front Immunol. 2021 Jan 11;11:599117. doi: 10.3389/fimmu.2020.599117. PMID: 33505394; PMCID: PMC7829336.
10. Fedewa MV, Hathaway ED, Ward-Ritacco CL. Effect of exercise training on C reactive protein: a systematic review and meta-analysis of randomised and non-randomised controlled trials. Br J Sports Med. 2017 Apr;51(8):670-676. doi: 10.1136/bjsports-2016-095999. Epub 2016 Jul 21. PMID: 27445361. 
11. Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology. 2004 May;29(4):448-74. doi: 10.1016/s0306-4530(03)00054-4. PMID: 14749092. 
12. Black DS, Slavich GM. Mindfulness meditation and the immune system: a systematic review of randomized controlled trials. Ann N Y Acad Sci. 2016 Jun;1373(1):13-24. doi: 10.1111/nyas.12998. Epub 2016 Jan 21. PMID: 26799456; PMCID: PMC4940234. 
13. Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med. 2006 Sep 18;166(16):1756-62. doi: 10.1001/archinte.166.16.1756. PMID: 16983055. 
14. Seifert B, Wagler P, Dartsch S, Schmidt U, Nieder J. Magnesium–eine therapeutische Alternative bei der primären Dysmenorrhoe [Magnesium–a new therapeutic alternative in primary dysmenorrhea]. Zentralbl Gynakol. 1989;111(11):755-60. German. PMID: 2675496. 
15. Salehpour S, Sene AA, Saharkhiz N, Sohrabi MR, Moghimian F. N-Acetylcysteine as an adjuvant to clomiphene citrate for successful induction of ovulation in infertile patients with polycystic ovary syndrome. J Obstet Gynaecol Res. 2012 Sep;38(9):1182-6. doi: 10.1111/j.1447-0756.2012.01844.x. Epub 2012 Apr 30. PMID: 22540635. 
16. Samimi, M., Mehrizi, M. Z., Foroozanfard, F., Akbari, H., Jamilian, M., Ahmadi, S., & Asemi, Z. (2017). The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Clinical Endocrinology, 86(4), 560-566. https://doi.org/10.1111/cen.13288 
17. Takahashi K, Yoshino K, Shirai T, Nishigaki A, Araki Y, Kitao M. Effect of a traditional herbal medicine (shakuyaku-kanzo-to) on testosterone secretion in patients with polycystic ovary syndrome detected by ultrasound. Nihon Sanka Fujinka Gakkai Zasshi. 1988;40(6):789-92. 
18. Zhu X, Li Q, Chang R, et al. Curcumin alleviates neuropathic pain by inhibiting p300/CBP histone acetyltransferase activity-regulated expression of BDNF and cox-2 in a rat model. PLoS One. 2014;9(3):e91303. doi:10.1371/journal.pone.0091303 
19. Agarwal D, Chaudhary P. Effect of Turmeric-Boswellia-Sesame Formulation in Menstrual Cramp Pain Associated with Primary Dysmenorrhea-A Double-Blind, Randomized, Placebo-Controlled Study. J Clin Med. 2023;12(12):3968. doi:10.3390/jcm12123968 
20. Ozgoli G, Goli M, Moattar F. Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea. J Altern Complement Med. 2009;15(2):129-132. doi:10.1089/acm.2008.0311
21. Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3):255-262. doi:10.4103/0253-7176.106022  

 

Author Bio:

Pamela Frank, BSc (Hons), ND is a licensed naturopathic doctor and Clinic Director of Forces of Nature Wellness in Toronto, with over 25 years of clinical experience. A graduate of the Canadian College of Naturopathic Medicine, she also brings two decades of prior experience as a medical laboratory technologist, giving her a strong foundation in diagnostic and evidence-based care. 

Dr. Frank’s practice focuses on women’s health, fertility, hormone balance, and digestive disorders, with particular expertise in conditions such as PCOS, endometriosis, acne, and infertility. She uses a root-cause, science-based approach that integrates advanced laboratory testing, nutrition, lifestyle medicine, botanical therapies, and targeted supplementation to deliver individualized treatment plans.